These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24080536)

  • 21. Smoking cessation in pregnancy: why, how, and what next..
    Crawford JT; Tolosa JE; Goldenberg RL
    Clin Obstet Gynecol; 2008 Jun; 51(2):419-35. PubMed ID: 18463471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.
    Meszaros ZS; Abdul-Malak Y; Dimmock JA; Wang D; Ajagbe TO; Batki SL
    J Clin Psychopharmacol; 2013 Apr; 33(2):243-7. PubMed ID: 23422399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.
    Suissa K; Larivière J; Eisenberg MJ; Eberg M; Gore GC; Grad R; Joseph L; Reynier PM; Filion KB
    Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28093398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C; Gonzales D; Nides M; Rennard S; Watsky E; Billing CB; Anziano R; Reeves K
    Arch Intern Med; 2006 Aug 14-28; 166(15):1571-7. PubMed ID: 16908789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
    Johnson TS
    J Am Acad Nurse Pract; 2010 Oct; 22(10):557-63. PubMed ID: 21040090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy.
    Wilson K; Hettle R; Marbaix S; Diaz Cerezo S; Ines M; Santoni L; Annemans L; Prignot J; Lopez de Sa E
    Eur J Prev Cardiol; 2012 Oct; 19(5):1173-83. PubMed ID: 21840967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varenicline and bupropion: suicide.
    Prescrire Int; 2012 Oct; 21(131):240. PubMed ID: 23189376
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.
    Tonstad S; Davies S; Flammer M; Russ C; Hughes J
    Drug Saf; 2010 Apr; 33(4):289-301. PubMed ID: 20297861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine dependence and smoking cessation.
    Tan L; Tang Q; Hao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1049-57. PubMed ID: 19952392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longer course of varenicline therapy improves smoking cessation rates.
    Lee JH; Jones PG; Bybee K; O'Keefe JH
    Prev Cardiol; 2008; 11(4):210-4. PubMed ID: 19476573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation.
    Kistler CE; Goldstein AO
    Nicotine Tob Res; 2012 Dec; 14(12):1391-3. PubMed ID: 22422928
    [No Abstract]   [Full Text] [Related]  

  • 33. Letter by Smolderen and Pelle regarding article, "Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial".
    Smolderen KG; Pelle AJ
    Circulation; 2010 Aug; 122(9):e445; author reply e446. PubMed ID: 20805437
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study.
    Svanström H; Pasternak B; Hviid A
    BMJ; 2012 Nov; 345():e7176. PubMed ID: 23138033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking cessation in patients with chronic kidney disease.
    Raymond CB; Naylor HK
    CANNT J; 2010; 20(4):24-9; quiz 30-1. PubMed ID: 21319580
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of varenicline as an aid to smoking cessation in primary care: an observational study.
    Andreas S; Chenot JF; Diebold R; Peachey S; Mann K
    Eur Addict Res; 2013; 19(1):47-54. PubMed ID: 22987095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database.
    Kotz D; Simpson C; Viechtbauer W; van Schayck OC; West R; Sheikh A
    BMJ Open; 2014 Aug; 4(8):e005281. PubMed ID: 25168037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C; Xiao D; Chan KP; Pothirat C; Garza D; Davies S
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
    Anthenelli RM; Morris C; Ramey TS; Dubrava SJ; Tsilkos K; Russ C; Yunis C
    Ann Intern Med; 2013 Sep; 159(6):390-400. PubMed ID: 24042367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of varenicline for smoking cessation.
    Keiding H
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.